Author

Aroa Soriano

Universitat Autònoma de BarcelonaORCID 0000-0001-9659-1471Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 2 Organism:human· 2 Approach:statistical model· 2 Approach:Bayesian inference· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1

Frequent Co-Authors

James CreedeniD· 2 shared Marcus OlivecronaiD· 2 shared Raquel HladuniD· 2 shared Amelie S. WenziD· 1 shared Asbleidy Carolina TorresiD· 1 shared Gabriel Gallo-OlleriD· 1 shared Gabriela GuilléniD· 1 shared Guillem PonsiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

James CreedenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintSep 11, 2026

Evaluation of AI-assisted summarisation of tertiary clinical genomics reports: results of the QNOMX-VHIR-CPSP-001 Phase 1 study

James Creeden, Marcus Olivecrona, Nuria Benavent…·Aroa Soriano

This study evaluates AI-generated summaries of pediatric cancer genomics reports, finding they are non-inferior to manual summaries in content and presentation.

DOI 10.64898/2026.09.10.26362656

humanwhole-genome sequencing

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintJun 22, 2026

A blinded, counterbalanced rater design for evaluating AI-assisted summarisation of tertiary clinical genomics reports: methodology of the QNOMX-VHIR-CPSP-001 Phase 1 study

James Creeden, Marcus Olivecrona, Aroa Soriano

This paper describes a blinded, counterbalanced study design to evaluate AI-assisted summarisation of clinical genomics reports using a quality rubric and statistical models.

1 citation

humanelectronic health records

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 3, 2024

Combined inhibition of MDM2 and PARP lead to a synergistic anti-tumoral response in p53 wild-type rhabdomyosarcoma models

Guillem Pons, Patricia Zarzosa, Gabriel Gallo-Oller…·Josep M Roma

This study shows that combining MDM2 and PARP inhibitors synergistically inhibits p53 wild-type rhabdomyosarcoma growth in vitro and in vivo.

DOI 10.1101/2024.12.03.626050

mousebulk RNA-seq

𝕏 PostBluesky